Search Orphan Drug Designations and Approvals
-
Generic Name: | modified a-cobratoxin |
---|---|
Date Designated: | 09/01/2015 |
Orphan Designation: | Treatment of pediatric multiple sclerosis (0 through 16 years of age). |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Nutra Pharma Corporation 12502 W. Atlantic Blvd Coral Springs, Florida 33071 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-